Protein kinase B/Akt plays an important role in regulating the transcription and sub-cellular distribution of p27 Kip1 . We therefore determined whether or not Akt is implicated in the EETinduced signaling cascade. Treatment of endothelial cells with 11,12-EET led to a concentration-(not shown) and time-dependent increase in the phosphorylation of Akt on Ser 473 (Fig. 3A) that was prevented by pre-incubation with the phosphatidylinositol 3-kinase (PI 3-K) inhibitor LY 294002 (Fig. 3B ).
LY 294002 also attenuated the 11,12-EET-induced decrease in p27 Kip1 levels (Fig. 4A ).
Moreover, transfection of HUVEC with a dominant negative Akt (Akt DN) almost completely prevented the EET-induced down regulation of p27 Kip1 ( Fig. 4B ). Transfection of HUVEC with a constitutively active Akt (Akt CA), on the other hand, decreased p27
Kip1 expression independently of the presence or absence of 11,12-EET, highlighting the importance of Akt in regulating p27 Kip1 expression in endothelial cells.
Effect of 11,12-EET on the activity forkhead transcription factors
As a possible molecular mechanism by which the EET-induced activation of Akt could regulate p27 Kip1 expression, we focused on the forkhead transcription factors, specifically on the FOXO subfamily, which is involved in the Akt-dependent regulation of cell proliferation and survival (21) . HUVEC express FOXO1 and FOXO3a (Fig. 5) , while FOXO4 could not be detected (not shown). 11,12-EET elicited the time-dependent phosphorylation of FOXO1 and FOXO3a ( Fig. 5A ), an effect that was abolished by pre-treatment of HUVEC with LY 294002 (Fig. 5B ).
Since 11,12-EET reduced p27 Kip1 promoter activity, and p27 Kip1 is a direct target of the forkhead transcription factors, we determined the involvement of FOXO3a in the EETinduced down regulation of p27 Kip1 . Co-transfection of HUVEC with the p27 Kip1 6B ). Similar results were obtained when FOXO1 was over-expressed in endothelial cells (data not shown).
The mitogenic effect of CYP-derived EETs depends on Akt and forkhead activity
To determine whether the effects observed are functionally involved in CYP 2C9-induced proliferation, BrdUrd incorporation was assessed in CYP 2C9 over-expressing HUVEC.
Similar to the effect of the CYP 2C9 product, 11,12-EET, CYP 2C9 over-expression resulted in a decrease in p27 Kip1 expression (data not shown) and a 2-fold increase in BrdUrd incorporation, compared to endothelial cells which were transfected with an empty vector (Fig. 7) . Over-expression of wild-type Akt in CYP 2C9-expressing endothelial cells did not influence BrdUrd incorporation but CYP 2C9 overexpression failed to elicit proliferation in endothelial cells that were co-transfected with a dominant negative Akt (Fig. 7A) . Moreover, the co-transfection of HUVEC with CYP 2C9 and either the wild-type or constitutively active FOXO3a completely prevented the CYP-induced proliferation of endothelial cells (Fig. 7B) (Fig. 8C) . The FOXO siRNA-induced proliferation of endothelial cells was such that we were unable to detect an additive effect of FOXO siRNA and CYP 2C9 overexpression.
Discussion
The results of the present investigation demonstrate that CYP 2C9-derived 11,12-EET promotes endothelial proliferation by down regulating the expression of the cyclin-dependent kinase inhibitor (CKI) p27 threshold for the activation of cyclin E and A-CDK2, the down regulation of these proteins is a requirement for mitogen-induced cell proliferation. Nuclear levels CDKI proteins are decreased by sequestration into the cytosol and once the level has decreased sufficiently, cyclin E-CDK2 can facilitate its own activation by phosphorylating p27 Kip1 , thus initiating its degradation (25) (26) (27) (28) (29) (30) . Indeed, the expression of p27 Kip1 is cell cycle-dependent and highest in quiescent cells, and decreases upon re-entry into the cell cycle (31).
Although phosphorylation was initially thought to determine cellular p27 Kip1 
